Validation of the 2-DeltaDeltaCt calculation as an alternate method of data analysis for quantitative PCR of BCR-ABL P210 transcripts.
作者： Alaina Arocho , Beiyun Chen , Marc Ladanyi , Qiulu Pan
DOI: 10.1097/00019606-200603000-00009
关键词:
摘要: Chronic myelogenous leukemia (CML) is a clonal myeloproliferative disorder that characterized by the presence of reciprocal translocation between chromosomes 9 and 22 results in formation Philadelphia (Ph1) chromosome present most CML patients. The Ph1 for
elsevier.com
lww.com
sci-hub.se 参考文章(21)
Adam Bagg, Chronic myeloid leukemia: a minimalistic view of post-therapeutic monitoring. The Journal of Molecular Diagnostics. ,vol. 4, pp. 1- 10 ,(2002) , 10.1016/S1525-1578(10)60675-7
V Montefusco, S Buonamici, M Amabile, N Testoni, E Ottaviani, S Soverini, S Tura, M Fiacchini, G Rosti, B Giannini, A de Vivo, C Terragna, G Saglio, M Baccarani, G Martinelli, S Bassi, C Zardini, E Trabacchi, F Pane, Real-time quantification of different types of bcr-abl transcript in chronic myeloid leukemia. Haematologica. ,vol. 86, pp. 252- 259 ,(2001) , 10.3324/%X
Lihui Wang, Kevin Pearson, Julia E. Ferguson, Richard E. Clark, The early molecular response to imatinib predicts cytogenetic and clinical outcome in chronic myeloid leukaemia British Journal of Haematology. ,vol. 120, pp. 990- 999 ,(2003) , 10.1046/J.1365-2141.2003.04200.X
S Branford, Z Rudzki, A Harper, A Grigg, K Taylor, S Durrant, C Arthur, P Browett, A P Schwarer, D Ma, J F Seymour, K Bradstock, D Joske, K Lynch, I Gathmann, T P Hughes, Imatinib produces significantly superior molecular responses compared to interferon alfa plus cytarabine in patients with newly diagnosed chronic myeloid leukemia in chronic phase. Leukemia. ,vol. 17, pp. 2401- 2409 ,(2003) , 10.1038/SJ.LEU.2403158
Tim Hughes, Susan Branford, Molecular monitoring of chronic myeloid leukemia. Seminars in Hematology. ,vol. 40, pp. 62- 68 ,(2003) , 10.1053/SHEM.2003.50044
Sharon R. Pine, FRED H. MOY, Joseph L. Wiemels, Ramneet K. Gill, Oya Levendoglu-Tugal, Mehmet F. Ozkaynak, Claudio Sandoval, Somasundaram Jayabose, Real-Time Quantitative PCR: Standardized Detection of Minimal Residual Disease in Pediatric Acute Lymphoblastic Leukemia Journal of Pediatric Hematology Oncology. ,vol. 25, pp. 103- 108 ,(2003) , 10.1097/00043426-200302000-00004
M C Müller, N Gattermann, T Lahaye, M W N Deininger, A Berndt, S Fruehauf, A Neubauer, T Fischer, D K Hossfeld, F Schneller, S W Krause, C Nerl, H G Sayer, O G Ottmann, C Waller, W Aulitzky, P le Coutre, M Freund, K Merx, P Paschka, H König, S Kreil, U Berger, H Gschaidmeier, R Hehlmann, A Hochhaus, Dynamics of BCR-ABL mRNA expression in first-line therapy of chronic myelogenous leukemia patients with imatinib or interferon alpha/ara-C. Leukemia. ,vol. 17, pp. 2392- 2400 ,(2003) , 10.1038/SJ.LEU.2403157
Michael W. N. Deininger, John M. Goldman, Junia V. Melo, The molecular biology of chronic myeloid leukemia Blood. ,vol. 96, pp. 3343- 3356 ,(2000) , 10.1182/BLOOD.V96.10.3343
Séverine Drunat, Martine Olivi, Ghislaine Brunie, Bernard Grandchamp, Etienne Vilmer, Ivan Bièche, Hélène Cavé, Quantification of TEL-AML1 transcript for minimal residual disease assessment in childhood acute lymphoblastic leukaemia. British Journal of Haematology. ,vol. 114, pp. 281- 289 ,(2001) , 10.1046/J.1365-2141.2001.02922.X
J Gabert, E Beillard, V H J van der Velden, W Bi, D Grimwade, N Pallisgaard, G Barbany, G Cazzaniga, J M Cayuela, H Cavé, F Pane, J L E Aerts, D De Micheli, X Thirion, V Pradel, M González, S Viehmann, M Malec, G Saglio, J J M van Dongen, Standardization and quality control studies of ‘real-time’ quantitative reverse transcriptase polymerase chain reaction of fusion gene transcripts for residual disease detection in leukemia – A Europe Against Cancer Program Leukemia. ,vol. 17, pp. 2318- 2357 ,(2003) , 10.1038/SJ.LEU.2403135